Skip to content
Trial Eligibility
Menu

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

NCT07097506

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to determine whether ingestion of a ketone ester drink helps improve liver health and blood glucose control. Ketones are a type of energy source made by the body during times of weight loss, low carbohydrate intake and starvation. People enrolled in this study will be randomly assigned (by chance, like the flip of a coin) to one of two groups: Group 1: Ketone ester drink consumed daily for 6 weeks. Group 2: Placebo drink consumed daily for 6 weeks.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
  • Obesity
  • Overweight (BMI > 25)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 40 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Washington University School of Medicine
Last updated on ClinicalTrials.gov
July 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Missouri · 1

  • Washington University School of Medicine · St Louis, MO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.